Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Samsu, N. (2023). Challenges in the Management of Nephrotic Syndrome. Jurnal Klinik Dan Riset Kesehatan, 3(1), 1-2. https://doi.org/10.11594/jk-risk.03.1.1
References
1. Thomé GG, Bianchini T, Bringhenti RN, Schaefer PG, Barros EJG, Veronese FV. The spectrum of biopsy-proven glomerular diseases in a tertiary Hospital in Southern Brazil. BMC Nephrol [Internet]. 2021;22(1):414.
2. Coates PT, Devuyst O, Wong G, Okusa M, Oliver J, York N, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. 2021;100(4).
3. Saleem MA. Molecular stratification of idiopathic nephrotic syndrome. Nat Rev Nephrol. 2019 Dec;15(12):750–65.
4. Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet (London, England). 2018 Jul;392(10141):61–74.
5. Sinnakirouchenan R. Medscape. 2023. Nephrotic Syndrome Treatment & Management.
2. Coates PT, Devuyst O, Wong G, Okusa M, Oliver J, York N, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. 2021;100(4).
3. Saleem MA. Molecular stratification of idiopathic nephrotic syndrome. Nat Rev Nephrol. 2019 Dec;15(12):750–65.
4. Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet (London, England). 2018 Jul;392(10141):61–74.
5. Sinnakirouchenan R. Medscape. 2023. Nephrotic Syndrome Treatment & Management.